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TriphenylphosphineAbstract 3,4-Dihydropyrimidin-2(1H)-one, 3,4-dihydropyrimidin-2(1H)-thione, and 3,4-dihydro-
pyrimidin-2(1H)-imine derivatives were synthesized bymodiﬁed Biginelli cyclocondensation reaction
catalyzed by triphenylphosphine as Lewis base. The structures of the synthesized compounds have
been elucidated by IR, 1H NMR and elemental analysis.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
TheBiginelli reaction (Kappe, 1993) is awell-known, simple and
straightforward procedure for the synthesis of 3,4-dihydropyri-
midinones (3,4-DHPMs) by the three-component condensation
of an aliphatic or aromatic aldehyde, b-ketoester and an urea.
The original reaction was ﬁrst reported by Biginelli (1893) and
was catalyzed by mineral acids. This simple procedure has been
successful in a number of Biginelli reactions involving substrateslacking sterically demanded groups. By the three-component
Biginelli condensation many 3,4-DHPMs have been synthe-
sized. These non-planarDHPMs represent a heterocyclic system
of remarkable pharmacological efﬁciency, including antiviral,
antibacterial and anti-inﬂammatory activities (Kappe, 1993).
More recently DHPMs have emerged as the integral backbones
of several calcium channelmodulators, anti-hypertensive agents
and a-1a-antagonists (Atwal et al., 1989, 1991; Rovnyak et al.,
1992; Kappe et al., 1997). Apart from synthetic DHPMs deriv-
atives, some alkaloids are isolated from marine sources with
interesting biological activities containing the dihydropyrimidine-
5-carboxylate core (Snider and Shi, 1993). 3,4-DHPMs are also
used as starting material for the synthesis of so called ‘supersta-
tin’ rosuvastatin selective and competitive inhibitor of HMG-
CoA reductase (Carswell et al., 2002), the enzyme responsible
for the biosynthesis of cholesterol. Moreover, the 3,4-DHPM
motif is present inmany products isolated from natural material
such as several species of sponges.
Figure 1 General structures of compounds 1–18.
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lytic systems involvement in solid phase, parallel and other com-
binatorial synthetic approaches contributed toward the
expansion of Biginelli cyclocondensation applications. The
three-component cyclocondensation reaction constituting alde-
hyde, b-ketoester, and urea in an acidic medium was reﬂuxed
using ethanolic/methanolic HCl in the classical synthesis while
other solvent-cum-acidic catalytic systems such as THF–HCl
and dioxane–HCl were also employed with H2SO4 as a replace-
able acidic source in later developments. The major drawbacks
associated with acid-catalyzed reactions were lower yields
(Kappe, 1993) (from 26% to 60%), particularly for tri- and
tetra-substituted aldehydes of aromatic and aliphatic origins
as well as extended reaction times from 24 to 36 h. The increas-
ing interest in this class of compounds led to the development of
other synthetic strategies with alternate catalysts.
Due to the importance of the Biginelli reaction products,
much work on improving the yields and reaction conditions
has been actively pursued. For example, Lewis acid catalysts
like Mn(OAc)3Æ2H2O (Kumar et al., 2001), Cu(OTf)2 (Paraskar
et al., 2003), VCl3 (Sabitha et al., 2003), Yb(OTf)3 (Ma et al.,
2000) and LaCl3Æ7H2O (Lu et al., 2004) have signiﬁcantly im-
proved the reaction output with reduced reaction times. The
polymer-supported, resin-bound isothiourea (Kappe, 2001),
poly(4-vinylpyridine-co-divinyl benzene–Cu-II) complex
(Yarapathi et al., 2004), ceria/vinyl-pyrimidine polymer nano-
composite (Sabitha et al., 2005), N-butyl-N,N-dimethyl-a-phe-
nyl-ethyl ammonium bromide (Reddy et al., 2003), and various
other catalysts have been successfully used for the synthesis of
Biginelli products. Further, aluminum hydrogen sulfate Al(H-
SO4)3 and potassium hydrogen sulfate KHSO4 were applied
with success as a source of both protic and metallic Lewis acids
(Tu et al., 2004; Khodaei et al., 2004). Several improved proce-
dures have been reported using heteropoly acids (Amini et al.,
2006; Heravi et al., 2006; Maradur and Gokavi, 2007) such as
H3PW12O40, H3PMo12O40, H3PMo11VO40 and propane phos-
phoric acid (Zumpe et al., 2007). On the other hand, this con-
densation was found to be equally effective when Lewis acids
were replaced by a strong Bro¨nsted base (KOH), but in this case
the reaction involves two steps (Anatoly et al., 1998). Therefore
synthesis of this type of heterocyclic compounds has been the
focus of much interest from organic and medicinal chemistry.
Many synthetic methods have been developed and Biginelli
reaction has gained an active ongoing research.
2. Experimental
Melting points are uncorrected. IR spectra were taken on a
Perkin–Elmer Joel 983 spectrometer. 1H NMR spectra were
recorded on a Bruker AM300 (300 MHz) spectrometer using
TMS as the internal standard. Column chromatography
employed silica gel of 100–200 mesh. Elemental analyses were
measured by means of Perkin–Elmer 2400 CHN elemental
analyzer ﬂowchart. Chemicals were purchased from Lancaster
or Fluka Ltd.
2.1. General procedure for the preparation of 3,4-
dihydropyrimidinones / thiones / imines
A mixture of aldehyde (2 mmol), ethyl acetoacetate
(2.5 mmol), urea/thiourea/guanidine (2.5 mmol) and triphenyl-
phosphine (0.2 mmol) was heated with stirring at 100 C for
8 h. After cooling, the reaction mixture was poured intocrushed ice with stirring. The crude product was ﬁltered,
washed with cold water, dried and recrystallized from 95%
ethanol or ethyl acetate to give pure products (1–18)
(80–90%). All compounds were fully characterized by elemen-
tal analysis, mp, IR and 1H NMR spectroscopy. The structures
of all synthesized compounds (1–18) have been depicted in
Fig. 1.2.1.1. 5-ethoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-one (1)
IR (KBr): 3420, 3217, 2885, 1711, 1641 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.08 (t, J= 7.1 Hz, 3H, CH3-10),
2.33 (s, 3H, CH3-7), 3.92 (q, J = 7.1, 4.8 Hz, 2H, CH2O-9),
5.22 (s, 1H, CH-4), 7.30–7.23 (m, 5H, Ar-H), 8.48 (s, 1H,
NH-3), 9.48 (s, 1H, NH-1). Anal. Calcd for C14H16N2O3: C,
64.62; H, 6.15; N, 10.72. Found: C, 64.58; H, 6.13; N, 10.72.2.1.2. 5-ethoxycarbonyl-6-methyl-4-(2-hydroxyphenyl)-3,4-
dihydropyrimidin-2(1H)-one (2)
IR (KBr): 3411, 3224, 2876, 1701, 1633 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.05 (t, J= 7.1 Hz , 3H, CH3-10),
2.24 (s, 3H, CH3-7), 3.94 (q, J= 7.1, 4.8 Hz, 2H, CH2O-9),
5.20 (s, 1H, CH-4), 4.10 (d, 1H, Ar-OH), 7.40–6.8 (m, 4H,
Ar-H), 8.40 (s,1H, NH-3), 9.20 (s, 1H, NH-1). Anal. Calcd
for C14H16N2O4: C, 60.86; H, 5.80; N, 10.14. Found: C,
60.88; H, 5.78; N, 10.18.2.1.3. 5-ethoxycarbonyl-6-methyl-4-(2-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-one (3)
IR (KBr): 3404, 3236, 2866, 1718, 1628 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.08 (t, J= 7.1 Hz , 3H, CH3-10),
2.22 (s, 3H, CH3-7), 3.92 (q, J= 7.1, 4.8 Hz, 2H, CH2O-9),
5.22 (s, 1H, CH-4), 7.30–6.9 (m, 4H, Ar-H), 8.10 (s, 1H,
NH-3), 9.12 (s, 1H, NH-1). Anal. Calcd for C14H15ClN2O3:
C, 57.14; H, 5.10; N, 9.52. Found: C, 57.10; H, 5.06; N, 9.56.
2.1.4. 5-ethoxycarbonyl-6-methyl-4-(3-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-one (4)
IR (KBr): 3422, 3222, 2866, 1704, 1628 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.06 (t, J= 7.1 Hz , 3H, CH3-10),
2.16 (s, 3H, CH3-7), 3.90 (q, J = 7.1, 4.8 Hz, 2H, CH2O-9),
5.30 (s, 1H, CH-4), 7.40–6.8 (m, 4H, Ar-H), 8.08 (s, 1H,
NH-3), 9.30 (s, 1H, NH-1). Anal. Calcd for C14H15ClN2O3:
C, 57.14; H, 5.10; N, 9.52. Found: C, 57.12; H, 5.08; N, 9.50.
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dihydropyrimidin-2(1H)-one (5)
IR (KBr): 3411, 3230, 2878, 1718, 1622 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.08 (t, J= 7.1 Hz , 3H, CH3-10),
2.18 (s, 3H, CH3-7), 3.94 (q, J= 7.1, 4.8 Hz, 2H, CH2O-9),
5.28 (s, 1H, CH-4), 7.30–6.80 (m, 4H, Ar-H), 7.92 (s, 1H,
NH-3), 9.04 (s, 1H, NH-1). Anal. Calcd for C14H15FN2O3:
C, 60.43; H, 5.39; N, 10.07. Found: C, 60.39; H, 5.36; N, 10.08.
2.1.6. 5-ethoxycarbonyl-6-methyl-4-(4-ﬂuorophenyl)-3,4-
dihydropyrimidin-2(1H)-one (6)
IR (KBr): 3418, 3220, 2866, 1700, 1628 cm1: 1H NMR (300
MHz, DMSO-d6): d 1.08 (t, J= 7.1 Hz , 3H, CH3-10), 2.22
(s, 3H, CH3-7), 3.92 (q, J= 7.1, 4.8 Hz, 2H, CH2O-9), 5.24
(s, 1H, CH-4), 7.40–6.85 (m, 4H, Ar-H), 8.18 (s, 1H, NH-3),
9.12 (s, 1H, NH-1). Anal. Calcd for C14H15FN2O3: C, 60.43;
H, 5.39; N, 10.07. Found: C, 60.40; H, 5.35; N, 10.10.
2.1.7. 5-ethoxycarbonyl-6-methyl-4-(2-chloroyphenyl)-3,4-
dihydropyrimidin-2(1H)-thione (7)
IR (KBr): 3422, 3344, 1712, 1668, 1366, 1288 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.04 (t, J= 7.2 Hz, 3H, CH3-10),
2.15 (s, 3H,CH3-7), 4.22 (q, J= 7.2, 4.3 Hz , 2H, CH2O-9),
4.22 (s, 1H, CH-4), 7.21–6.81 (m, 4H, Ar-H), 8.46 (s, 1H,
NH-3), 9.57 (s, 1H, NH-1). Anal. Calcd for C14H15ClN2O2S:
C, 54.19; H, 4.84; N, 9.03; S, 10.32. Found: C, 54.15; H,
4.80; N, 9.05; S, 10.30.
2.1.8. 5-ethoxycarbonyl-6-methyl-4-(4-methoxyphenyl)-3,4-
dihydropyrimidin-2(1H)-thione (8)
IR (KBr): 3426, 3134, 2982, 1698, 1633, 1325, 1287 cm1: 1H
NMR (300 MHz, DMSO-d6): d 1.20 (t, J= 7.9 Hz, 3H,
CH3-10), 2.34 (s, 3H, CH3-7), 3.88 (s, 3H, Ar-OCH3-4
0), 4.12
(q, J= 7.9, 4.6 Hz, 2H, CH2O-9), 5.26 (s, 1H, CH-4), 6.9 (s,
1H, NH-3), 7.81–6.84 (m, 4H, Ar-H), 9.56 (s, 1H, NH-1).
Anal. Calcd for C15H18N2O3S: C, 58.82; H, 5.88; N, 9.15; S,
10.45. Found: C, 58.78; H, 5.86; N, 9.16; S, 10.43.
2.1.9. 5-ethoxycarbonyl-6-methyl-4-(2-nitrophenyl)-3,4-
dihydropyrimidin-2(1H)thione (9)
IR (KBr): 3322, 3266, 2980, 1690, 1622, 1366, 1320 cm1: 1H
NMR (300 MHz, DMSO-d6): d 1.18 (t, J= 7.2 Hz, 3H,
CH3-10), 2.0 (s, 3 H, CH3-7), 4.12 (q, J= 7.2, 4.3 Hz, 2H,
CH2O-9), 5.11 (s, 1H, CH-4), 7.4–6.8 (m, 4H, Ar-H): 7.43 (s,
1H, NH-3), 9.26 (s, 1H, NH-1). Anal. Calcd for C14H15N3O4S:
C, 52.33; H, 4.67; N, 13.08; S, 9.97. Found: C, 52.30; H, 4.66;
N, 13.10; S, 9.99.
2.1.10. 5-ethoxycarbonyl-6-methyl-4-(3-nitrorophenyl)-3,4-
dihydropyrimidin-2(1H)-thione (10)
IR (KBr): 3426, 3278, 2966, 1718, 1628, 1344, 1278 cm1: 1H
NMR (300 MHz, DMSO-d6): d 1.18 (t, J= 7.5 Hz, 3H,
CH3-10), 2.23 (s, 3H,CH3-7), 4.12 (q, J= 7.4, 4.4 Hz, 2H,
CH2O-9), 4.12 (s, 1H, CH-4), 7.29–6.23 (m, 4H, Ar-H), 7.40
(s, 1H, NH-3), 9.32 (s, 1H, NH-1). Anal. Calcd for
C14H15N3O4S: C, 52.33; H, 4.67; N, 13.08; S, 9.97. Found:
C, 52.30; H, 4.66; N, 13.09; S, 9.98.
2.1.11. 5-ethoxycarbonyl-6-methyl-4-(3-methoxyphenyl)-3,4-
dihydropyrimidin-2(1H)-thione (11)
IR (KBr): 3418, 3146, 2958, 1700, 1622, 1318, 1278 cm1: 1H
NMR (300 MHz, DMSO-d6): d 1.20 (t, J= 7.9 Hz, 3H,CH3-10), 2.34 (s, 3H, CH3-7), 3.88 (s, 3H, Ar-OCH3-4
0), 4.12
(q, J= 7.9, 4.6 Hz, 2H, CH2O-9), 5.26 (s, 1H, CH-4), 6.8 (s,
1H, NH-3), 7.81–6.84 (m, 4H, Ar-H), 9.5 (s, 1H, NH-1). Anal.
Calcd for C15H18N2O3S: C, 58.82; H, 5.88; N, 9.15; S, 10.45.
Found: C, 58.78; H, 5.86; N, 9.16; S, 10.44.
2.1.12. 5-ethoxycarbonyl-6-methyl-4-(4-N,N-
dimethylaminophenyl)-3,4-dihydropyrimidin-2(1H)-thione (12)
IR (KBr): 3330, 3124, 2944, 1690, 1618, 1320, 1282 cm1: 1H
NMR (300 MHz, DMSO-d6): d 1.16 (t, J= 7.9 Hz , 3H,
CH3-10), 2.40 (s, 3H, CH3-7), 5.47 (s, 1H, CH-4), 2.71 (s,
6H, N(CH3)2), 3.35 (q, J= 7.9, 4.4 Hz, 2H, CH2O-9), 8.21
(s, 1H, NH-3), 9.48 (s, 1H, NH-1), 7.30–7.23 (m, 4H, Ar-H).
Anal. Calcd for C16H21N3O2S: C, 60.19; H, 6.58; N, 13.16;
S, 10.03. Found C, 60.16; H, 6.56; N, 13.14; S, 10.06
2.1.13. 5-ethoxycarbonyl-6-methyl-4-phenyl-3,4-
dihydropyrimidin-2(1H)-imine (13)
IR (KBr): 3340, 3287, 2875, 1700, 1641,1330 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.09 (t, J= 7.1 Hz , 3H, CH3-10),
2.33 (s, 3H, CH3-7), 3.34 (s, 1H, ‚NH-2), 4.08 (q, J= 7.1,
4.8 Hz, 2H, CH2O-9), 5.30 (s, 1H, CH-4), 7.30–7.23 (m, 5H,
Ar-H), 8.4 (s, 1H, NH-3), 9.4 (s, 1H, NH-1). Anal. Calcd for
C14H17N3O2: C, 64.86; H, 6.56; N, 16.21. Found: C, 64.84;
H, 6.54; N, 16.20.
2.1.14. 5-ethoxycarbonyl-6-methyl-4-(4-methylphenyl)-3,4-
dihydropyrimidin-2(1H)-imine (14)
IR (KBr): 3222, 3120, 2978, 1692, 1650, 1344 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.09 (t, J= 7.9 Hz, 3H, CH3-10),
2.40 (s, 3H, CH3-7), 5.47 (s, 1H, CH-4), 1.64 (s, 3H, Ar-
CH3-4
0), 3.27 (s, 1H, ‚NH-2), 3.35 (q, J= 7.9, 4.4 Hz, 2H,
CH2O-9), 7.30–6.94 (m, 4H, Ar-H), 7.22 (s, 1H, NH-3), 9.22
(s, 1H, NH-1). Anal. Calcd for C15H19N3O2: C, 65.59; H,
6.96; N, 15.38. Found: C, 65.58; H, 6.96; N, 15.40.
2.1.15. 5-ethoxycarbonyl-6-methyl-4-(2,3,4-trimethoxyphenyl)-
3,4-dihydropyrimidin-2(1H)-imine (15)
IR (KBr): 3257, 3104, 2976, 1711, 1641, 1330 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.09 (t, J= 7.9 Hz, 3H, CH3-10),
2.40 (s, 3H, CH3-7), 5.47 (s, 1H, CH-4), 3.27 (s, 1H, ‚NH-
2), 3.35 (q, J= 7.9, 4.4 Hz, 2H, CH2O-9), 3.80 (s, 3H,
Ar-OCH3-2
0), 3.84 (s, 3H, Ar-OCH3-30), 3.70 (s, 3H,
Ar-OCH3-4
0), 7.44 (s, 1H, NH-3), 7.30–7.06 (m, 2H, Ar-H),
8.88 (s, 1H, NH-1). Anal. Calcd for C17H23N3O5: C, 58.45;
H, 6.59; N, 12.03. Found: C, 58.44; H, 6.58; N, 12.02.
2.1.16. 5-ethoxycarbonyl-6-methyl-4-(4-methoxyphenyl)-3,4-
dihydropyrimidin-2(1H)-imine (16)
IR (KBr): 3371, 3134, 2975, 1698, 1641, 1322 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.09 (t, J= 7.9 Hz, 3H, CH3-10),
2.40 (s, 3 H, CH3-7), 5.47(s, 1H, CH-4), 3.27 (s, 1H, ‚NH-
2), 3.35 (q, J= 7.9, 4.4 Hz, 2H, CH2O-9), 3.78 (s, 3H,
Ar-OCH3-4
0), 7.33–6.98 (m, 4H, Ar-H), 7.31 (s, 1H, NH-3),
9.97 (s, 1H, NH-1). Anal. Calcd for C15H19N3O3: C, 60.17;
H, 6.63; N, 13.16. Found: C, 60.21; H, 6.65; N, 13.14.
2.1.17. 5-ethoxycarbonyl-6-methyl-4-(4-N,N-
dimethylaminophenyl)-3,4-dihydropyrimidin-2(1H)-imine (17)
IR (KBr): 3319, 3114, 2965, 1690, 1650, 1318 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.09 (t, J= 7.9 Hz, 3H, CH3-10),
2.40 (s, 3H, CH3-7), 5.47 (s, 1H, CH-4), 3.27 (s, 1H, ‚NH-
Scheme 1 General synthetic scheme of compounds 1–18.
Table 1 Triphenylphosphine catalyzed synthesis of dihydropyrimidines in different solventsa and under solvent-free conditions at
100 Cb.
Entry Solvent Amount of PPh3 (mol%) Time (h) Yield (%)
1 Ethanol 10 16 10
2 Acetonitrile 10 16 10
3 Toluene 10 16 30
4 Dichloromethane 10 16 25
5 Cyclohexane 10 16 25
6 Solvent free 10 8 62
7 Solvent free 15 8 54
8 Solvent free 20 8 50
9 Solvent free 5 8 52
10 Solvent free 10 8 80c
a Reﬂux temperature.
b Benzaldehyde/ethyl acetoacetate/urea 1:1:1.
c Benzaldehyde/ethyl acetoacetate/urea 1:1.25:1.25.
Table 2 Triphenylphosphine catalyzed synthesis of 3,4-dihydropyrimidinones/thione and imine derivatives.
Code R Substitution X Molecular formula M.pt. (C) Yield (%)
1 H O C14H16N2O3 204–206 80
2 2-Hydroxy O C14H16N2O4 210–212 88
3 2-Chloro O C14H15ClN2O3 206–208 90
4 3-Chloro O C14H15ClN2O3 198–200 90
5 3-Fluoro O C14H15FN2O3 180–182 86
6 4-Fluoro O C14H15FN2O3 186–188 90
7 2-Chloro S C14H15ClN2O2S 218–220 84
8 4-Methoxy S C15H18N2O3S 140–142 82
9 2-Nitro S C14H15N3O4S 190–192 90
10 3-Nitro S C14H15ClN2O3S 214–216 90
11 3-Methoxy S C14H15N3O4S 160–162 86
12 4-N,N-dimethyl amino S C16H21N3O2S 208–210 90
13 H NH C14H17N3O2 175–177 84
14 4-Methyl NH C14H19N3O2 122–124 90
15 2,3,4-Trimethoxy NH C17H23N3O3 124–126 84
16 4-Methoxy NH C15H19N3O3 108–110 82
17 4-N,N-dimethyl amino NH C16H22N4O2 162–164 80
18 3-Chloro NH C14H16ClN3O2 144–146 80
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9), 8.21 (s, 1H, NH-3), 9.48 (s, 1H, NH-1), 7.20–6.90 (m, 4H,
Ar-H). Anal. Calcd for C16H22N4O2: C, 62.28; H, 6.57; N,
14.53. Found: C, 62.26; H, 6.54; N, 14.56.2.1.18. 5-ethoxycarbonyl-6-methyl-4-(3-chlorophenyl)-3,4-
dihydropyrimidin-2(1H)-imine (18)
IR (KBr): 3338, 3280, 2870, 1700, 1646, 1326 cm1: 1H NMR
(300 MHz, DMSO-d6): d 1.16 (t, J= 7.1 Hz , 3H, CH3-10),
Scheme 2 Suggested mechanism for the Biginelli reaction catalyzed by triphenylphosphine under solvent-free conditions. (See above-
mentioned references for further information.)
S850 S. Sheik Mansoor et al.2.33 (s, 3H, CH3-7), 3.34 (s, 1H, =NH-2), 3.90 (q, J= 7.1,
4.8 Hz, 2H, CH2O-9), 5.30 (s, 1H, CH-4), 7.32–6.98 (m, 4H,
Ar-H), 8.4 (s, 1H, NH-3), 9.4 (s, 1H, NH-1). Anal. Calcd for
C14H16ClN3O2: C, 57.34; H, 5.46; N, 14.33. Found: C, 57.30;
H, 5.44; N, 14.36.3. Results and discussion
Dihydropyrimidines show a diverse range of biological
activities. We are interested in studying Biginelli reaction with
the aim to develop an operationally simple method for the
An efﬁcient one-pot multicomponent synthesis of 3,4-dihydropyrimidine-2-(1H)-ones/thiones/imines S851synthesis of a large range of DHPMs. We started our study of
the one-pot three-component Biginelli condensation using
triphenylphosphine as the catalyst (Scheme 1), by examining
the conditions for the reaction using benzaldehyde, ethylace-
toacetate and urea to afford the corresponding DHPM prod-
uct. We studied the reaction in different solvents including
ethanol, acetonitrile, toluene, dichloromethane, cyclohexane
and under solvent-free conditions at 100 C (Table 1). The best
results were obtained under solvent-free conditions (entry 6).
The reaction is optimized for the amount of triphenylphos-
phine required (entries 7–10) and the optimum amount was
found to be 10 mol%. In order to improve the yields, the
reaction is performed using different quantities of reagents.
The best results were obtained with a 1:1.25:1.25:0.1 ratio of
benzaldehyde, ethylacetoacetate, urea, and triphenylphos-
phine, respectively.
In order to investigate the scope of these conditions, we
have undertaken the synthesis of different derivatives of
3,4-dihydropyrimidin-2(1H)-one (1–6), 3,4-dihydropyrimidin-
2(1H)-thione (7–12), and 3,4-dihydropyrimidin-2(1H)-imine
(13–18) from a variety of substrates from aromatic aldehydes,
ethylacetoacetate (Kappe, 2001) and either urea/thiourea or
guanidine in the presence of triphenylphosphine (PPh3) as cat-
alyst. The benzaldehyde derivatives with substitutions in the
aromatic ring with 4-methyl, n-halogens (n= varying ring
substitution positions), 2-hydroxy, n-methoxy, varying nitro
positions and N,N-dimethylamino groups were reacted with
urea, thiourea, and guanidine to furnish a series of products
1–18 (Scheme 1, Table 2).
The mechanism of the Biginelli reaction established by
Kappe (1997) proposed that the key step in this cycloconden-
sation process should involve the formation of N-acyliminium
ion intermediate. The suggested mechanism for the Biginelli
reaction catalyzed by triphenylphosphine under solvent-free
conditions is outlined in Scheme 2.4. Conclusions
In summary, we have described a novel method for the prepa-
ration of substituted dihydropyrimidinones/thiones/imines cat-
alyzed by triphenylphosphine (PPh3) as Lewis base under
neutral and solvent-free conditions. Moderate to good yields
of the corresponding DHPMs were obtained from readily
available starting materials.Acknowledgment
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